ALMR — Alamar Biosciences, Inc.

—
Nasdaq · Unknown · Unknown · CIK 2104204 ·
Last close
$30.64
Market Cap
$2.13B
52W High
$39.61
52W Low
$18.85
ADV30
790,396
Next earnings
2026-11-03

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 33,545,000 20,644,000 -15,139,000 -13,342,000 378,027,000 121,532,000 74,323,000
Jun 2026 29,427,000 17,718,000 -13,532,000 -13,199,000 390,975,000 132,969,000 78,118,000
Mar 2026 26,035,000 14,457,000 -12,347,000 -21,325,000 186,451,000 64,586,000 364,522,000
Dec 2025 25,045,000 14,838,000 -6,977,000 -7,136,000 139,992,000 30,002,000 298,946,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-60,920,000
Investing CF
$-112,813,000
Financing CF
$247,781,000
CapEx
$-8,127,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.85
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-216,641,000
Inventory
$54,133,000
Receivables
$21,611,000
ST Investments
$105,053,000
EBIT TTM
$-53,490,000
Pretax Income TTM
$-54,312,000
Interest Exp TTM
$822,000
Analysts
5

Yahoo Snapshot (yfinance, live)

Total Revenue
$114,052,000
EBITDA
$-44,296,000
Free Cash Flow
—
Enterprise Value
$1,764,725,248
Total Cash
$226,584,992
Total Debt
$42,350,000
Shares Out
69,481,651
Trailing EPS
$-1.13
Book Value
$4.37
ROE
—
ROA
—
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 2y)

Revenues vs Net Income (last 2y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 74,211,000 -31,334,000 -29,819,000 139,992,000 298,946,000 -158,954,000 -53,608,000
Dec 2024 25,142,000 -49,568,000 -47,073,000 149,511,000 282,922,000 -133,411,000 -55,214,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$390,975,000
Forward EPS
$-0.12

Peers — same industry

TickerNameMarket CapLastDaily %
EBCRY Embracer Group AB/ADR $2.14B $10.18 —
NZF Nuveen Municipal Credit Income Fund $2.12B $10.78 —
MH McGraw Hill, Inc. $2.15B $11.26 —
WLY JOHN WILEY & SONS, INC. $2.10B $50.17 —
LB LandBridge Corp $2.10B $70.81 —

News headlines (Yahoo Finance, 1h cache)

Alamar Biosciences Highlights NULISA Data in 46 Presentations at CTAD 2026, Including 10 Oral Presentations
2026-11-16 11:00 · Yahoo
Is GSK (LSE:GSK) A Bargain Following Its New Alamar Collaboration?
2026-11-13 00:18 · Yahoo
Why Is GSK (LSE:GSK) Drawing Attention For New Cancer Data And Proteomics?
2026-11-09 19:15 · Yahoo
Does Alamar Biosciences (ALMR) Sit Above Fair Value After The Selloff?
2026-11-05 13:13 · Yahoo
Alamar Biosciences to Participate in Upcoming Investor Conferences
2026-11-04 21:05 · Yahoo
Alamar Biosciences (ALMR) Q3 2026 Earnings Call Transcript
2026-11-04 16:32 · Yahoo
Alamar Biosciences (ALMR) Could Be 15% Undervalued On Q3 Results And Guidance
2026-11-04 08:12 · Yahoo
Alamar Biosciences Inc (ALMR) (Q3 2026) Earnings Call Highlights: Revenue Jumps 68% as Guidance ...
2026-11-04 05:10 · Yahoo
Alamar Biosciences Q3 Earnings Call Highlights
2026-11-04 00:14 · Yahoo
Alamar (ALMR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
2026-11-03 22:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.